drugset / Trial / NCT04053140

Closed-loop Control of Penicillin Delivery

NCT04053140

Phase 1 Completed 6 enrolled Imperial College London
Non-randomizedSingle-groupOpen-labelDevice feasibility

Summary

This study is an in-house feasibility study of penicillin biosensor technology linked with closed-loop control for the automated delivery of penicillin antibiotics.

Timeline

Start
2019-11-05
Primary completion
2024-05-31
Completion
2024-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Benzylpenicillin Unknown 600 mg Intravenous
Subject Benzylpenicillin Unknown 1200 mg Intravenous
Subject Benzylpenicillin Unknown 2400 mg Intravenous

Indications

No indication recorded.